Gainers
- ContraFect CFRX stock moved upwards by 4.9% to $2.76 during Friday's after-market session. The company's market cap stands at $108.5 million.
- Lexaria Bioscience LEXX shares moved upwards by 4.76% to $4.51. The market value of their outstanding shares is at $26.8 million.
- Atossa Therapeutics ATOS shares moved upwards by 4.57% to $1.6. The company's market cap stands at $202.5 million.
- Enveric Biosciences ENVB shares rose 4.42% to $0.9. The market value of their outstanding shares is at $29.4 million.
- Axsome Therapeutics AXSM shares moved upwards by 4.26% to $34.5. The market value of their outstanding shares is at $1.3 billion.
- Quoin Pharmaceuticals QNRX stock moved upwards by 4.02% to $1.81. The company's market cap stands at $15.1 million.
Losers
- Graphite Bio GRPH shares decreased by 6.2% to $10.4 during Friday's after-market session. The market value of their outstanding shares is at $604.0 million.
- Plus Therapeutics PSTV shares declined by 6.07% to $1.24. At the close, Plus Therapeutics's trading volume reached 128.0K shares. This is 5.2% of its average volume over the last 100 days. The company's market cap stands at $19.0 million.
- Ikena Oncology IKNA stock decreased by 5.43% to $11.5. The market value of their outstanding shares is at $412.9 million.
- Ensysce Biosciences ENSC shares decreased by 5.27% to $4.5. Today's trading volume for this security ended up closing at 141.5K shares, which is 2.1 percent of its average volume over the last 100 days. The company's market cap stands at $109.1 million.
- China SXT Pharmaceuticals SXTC stock declined by 5.04% to $0.51. The company's market cap stands at $7.8 million.
- Reshape Lifesciences RSLS stock fell 5.04% to $1.51. The company's market cap stands at $5.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in